HEADER SIGNALING PROTEIN 30-JAN-17 5UNG TITLE XFEL STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR (ORTHORHOMBIC TITLE 2 FORM) IN COMPLEX WITH COMPOUND 1 (N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2'- TITLE 3 (2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL] METHYL}-3,4- TITLE 4 DIHYDROQUINAZOLIN-6-YL)THIOPHENE-2-CARBOXAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHIMERA PROTEIN OF TYPE-2 ANGIOTENSIN II RECEPTOR AND COMPND 3 SOLUBLE CYTOCHROME B562; COMPND 4 CHAIN: B; COMPND 5 FRAGMENT: UNP P0ABE7 RESIDUES 23-128 AND UNP P50052 35-335 LINKED VIA COMPND 6 LINKER RESDIUES GSGS; COMPND 7 SYNONYM: CYTOCHROME B-562,ANGIOTENSIN II TYPE-2 RECEPTOR,AT2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 562, 9606; SOURCE 5 GENE: CYBC, AGTR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9 KEYWDS HUMAN ANGIOTENSIN II RECEPTOR COMPLEX, GPCR SIGNALING, GPCR, BRIL, KEYWDS 2 MEMBRANE PROTEIN, LCP, XFEL, BLOOD PRESSURE REGULATION, ORTHORHOMBIC KEYWDS 3 CRYSTAL, COMPOUND 1 (CPD 1), SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.ZHANG,G.W.HAN,A.BATYUK,A.ISHCHENKO,K.L.WHITE,N.PATEL,A.SADYBEKOV, AUTHOR 2 B.ZAMLYNNY,M.T.RUDD,K.HOLLENSTEIN,A.TOLSTIKOVA,T.A.WHITE,M.S.HUNTER, AUTHOR 3 U.WEIERSTALL,W.LIU,K.BABAOGLU,E.L.MOORE,R.D.KATZ,J.M.SHIPMAN, AUTHOR 4 M.GARCIA-CALVO,S.SHARMA,P.SHETH,S.M.SOISSON,R.C.STEVENS,V.KATRITCH, AUTHOR 5 V.CHEREZOV REVDAT 4 04-OCT-23 5UNG 1 REMARK REVDAT 3 28-NOV-18 5UNG 1 REMARK REVDAT 2 10-MAY-17 5UNG 1 JRNL REMARK REVDAT 1 05-APR-17 5UNG 0 JRNL AUTH H.ZHANG,G.W.HAN,A.BATYUK,A.ISHCHENKO,K.L.WHITE,N.PATEL, JRNL AUTH 2 A.SADYBEKOV,B.ZAMLYNNY,M.T.RUDD,K.HOLLENSTEIN,A.TOLSTIKOVA, JRNL AUTH 3 T.A.WHITE,M.S.HUNTER,U.WEIERSTALL,W.LIU,K.BABAOGLU, JRNL AUTH 4 E.L.MOORE,R.D.KATZ,J.M.SHIPMAN,M.GARCIA-CALVO,S.SHARMA, JRNL AUTH 5 P.SHETH,S.M.SOISSON,R.C.STEVENS,V.KATRITCH,V.CHEREZOV JRNL TITL STRUCTURAL BASIS FOR SELECTIVITY AND DIVERSITY IN JRNL TITL 2 ANGIOTENSIN II RECEPTORS. JRNL REF NATURE V. 544 327 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28379944 JRNL DOI 10.1038/NATURE22035 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.210 REMARK 3 FREE R VALUE TEST SET COUNT : 691 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2693 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2400 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2544 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.53 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 149 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3195 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 1 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 80.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 82.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.17680 REMARK 3 B22 (A**2) : 4.93740 REMARK 3 B33 (A**2) : -2.76060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.490 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 2.894 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.357 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 2.685 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.363 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3351 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4557 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1105 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 61 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 483 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3351 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 441 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3803 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.92 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.37 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { B| 1001 - 1110 } REMARK 3 ORIGIN FOR THE GROUP (A): 22.6292 36.8452 -13.5705 REMARK 3 T TENSOR REMARK 3 T11: -0.0262 T22: -0.1488 REMARK 3 T33: -0.0310 T12: -0.0029 REMARK 3 T13: 0.0075 T23: -0.0382 REMARK 3 L TENSOR REMARK 3 L11: 1.3494 L22: 2.9298 REMARK 3 L33: 3.5237 L12: 0.7639 REMARK 3 L13: 1.7428 L23: -0.3012 REMARK 3 S TENSOR REMARK 3 S11: -0.0137 S12: 0.0173 S13: -0.0525 REMARK 3 S21: -0.0295 S22: 0.0197 S23: 0.1097 REMARK 3 S31: -0.0332 S32: 0.0294 S33: -0.0061 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B| 35 - 334 } REMARK 3 ORIGIN FOR THE GROUP (A): 9.7938 -1.6740 -19.1740 REMARK 3 T TENSOR REMARK 3 T11: -0.2334 T22: -0.2102 REMARK 3 T33: -0.0545 T12: -0.0055 REMARK 3 T13: -0.0540 T23: 0.0207 REMARK 3 L TENSOR REMARK 3 L11: 1.3717 L22: 3.2587 REMARK 3 L33: 1.9040 L12: 0.6911 REMARK 3 L13: 0.0630 L23: 0.0219 REMARK 3 S TENSOR REMARK 3 S11: 0.0973 S12: -0.1024 S13: 0.0360 REMARK 3 S21: 0.2630 S22: 0.0820 S23: 0.0795 REMARK 3 S31: 0.0691 S32: -0.1515 S33: -0.1793 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UNG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226079. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 294 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : CXI REMARK 200 X-RAY GENERATOR MODEL : SLAC LCLS BEAMLINE CXI REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.3 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : K-B MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : CS-PAD CXI-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13330 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 28.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 85.50 REMARK 200 R MERGE (I) : 0.14800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 27.20 REMARK 200 R MERGE FOR SHELL (I) : 1.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YAY, 4ZUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL, PH 8.0, 25 MM REMARK 280 POTASSIUM FORMATE, 25% (V/V) PEG400, AND 0.3% (V/V) (+/-)-2- REMARK 280 METHYL-2,4-PENTANEDIOL, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.70500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.70500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL B 335 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B1042 CE NZ REMARK 470 SER B 36 OG REMARK 470 LYS B 38 CG CD CE NZ REMARK 470 ASP B 41 CG OD1 OD2 REMARK 470 HIS B 43 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 44 CG CD1 CD2 REMARK 470 GLN B 72 CG CD OE1 NE2 REMARK 470 LYS B 77 CG CD CE NZ REMARK 470 ARG B 154 CD NE CZ NH1 NH2 REMARK 470 ARG B 155 CZ NH1 NH2 REMARK 470 TRP B 158 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 158 CZ3 CH2 REMARK 470 GLU B 188 CG CD OE1 OE2 REMARK 470 THR B 241 OG1 CG2 REMARK 470 GLN B 326 CG CD OE1 NE2 REMARK 470 ARG B 330 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 333 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 334 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 72 -10.03 -153.37 REMARK 500 LYS B 73 -62.72 -133.55 REMARK 500 LYS B 77 142.35 70.76 REMARK 500 LEU B 111 43.75 -106.71 REMARK 500 PRO B 157 59.27 -94.07 REMARK 500 PHE B 220 -51.38 -140.15 REMARK 500 ASN B 242 71.61 56.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC B 1202 REMARK 610 OLA B 1203 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8ES B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC B 1202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UNF RELATED DB: PDB REMARK 900 RELATED ID: 5UNH RELATED DB: PDB DBREF 5UNG B 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 5UNG B 35 335 UNP P50052 AGTR2_HUMAN 35 335 SEQADV 5UNG TRP B 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 5UNG ILE B 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 5UNG LEU B 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 5UNG GLY B 1107 UNP P0ABE7 LINKER SEQADV 5UNG SER B 1108 UNP P0ABE7 LINKER SEQADV 5UNG GLY B 1109 UNP P0ABE7 LINKER SEQADV 5UNG SER B 1110 UNP P0ABE7 LINKER SEQRES 1 B 411 ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN SEQRES 2 B 411 LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL SEQRES 3 B 411 LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP SEQRES 4 B 411 ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER SEQRES 5 B 411 PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE SEQRES 6 B 411 ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU SEQRES 7 B 411 ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA SEQRES 8 B 411 GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS SEQRES 9 B 411 TYR LEU GLY SER GLY SER CYS SER GLN LYS PRO SER ASP SEQRES 10 B 411 LYS HIS LEU ASP ALA ILE PRO ILE LEU TYR TYR ILE ILE SEQRES 11 B 411 PHE VAL ILE GLY PHE LEU VAL ASN ILE VAL VAL VAL THR SEQRES 12 B 411 LEU PHE CYS CYS GLN LYS GLY PRO LYS LYS VAL SER SER SEQRES 13 B 411 ILE TYR ILE PHE ASN LEU ALA VAL ALA ASP LEU LEU LEU SEQRES 14 B 411 LEU ALA THR LEU PRO LEU TRP ALA THR TYR TYR SER TYR SEQRES 15 B 411 ARG TYR ASP TRP LEU PHE GLY PRO VAL MET CYS LYS VAL SEQRES 16 B 411 PHE GLY SER PHE LEU THR LEU ASN MET PHE ALA SER ILE SEQRES 17 B 411 PHE PHE ILE THR CYS MET SER VAL ASP ARG TYR GLN SER SEQRES 18 B 411 VAL ILE TYR PRO PHE LEU SER GLN ARG ARG ASN PRO TRP SEQRES 19 B 411 GLN ALA SER TYR ILE VAL PRO LEU VAL TRP CYS MET ALA SEQRES 20 B 411 CYS LEU SER SER LEU PRO THR PHE TYR PHE ARG ASP VAL SEQRES 21 B 411 ARG THR ILE GLU TYR LEU GLY VAL ASN ALA CYS ILE MET SEQRES 22 B 411 ALA PHE PRO PRO GLU LYS TYR ALA GLN TRP SER ALA GLY SEQRES 23 B 411 ILE ALA LEU MET LYS ASN ILE LEU GLY PHE ILE ILE PRO SEQRES 24 B 411 LEU ILE PHE ILE ALA THR CYS TYR PHE GLY ILE ARG LYS SEQRES 25 B 411 HIS LEU LEU LYS THR ASN SER TYR GLY LYS ASN ARG ILE SEQRES 26 B 411 THR ARG ASP GLN VAL LEU LYS MET ALA ALA ALA VAL VAL SEQRES 27 B 411 LEU ALA PHE ILE ILE CYS TRP LEU PRO PHE HIS VAL LEU SEQRES 28 B 411 THR PHE LEU ASP ALA LEU ALA TRP MET GLY VAL ILE ASN SEQRES 29 B 411 SER CYS GLU VAL ILE ALA VAL ILE ASP LEU ALA LEU PRO SEQRES 30 B 411 PHE ALA ILE LEU LEU GLY PHE THR ASN SER CYS VAL ASN SEQRES 31 B 411 PRO PHE LEU TYR CYS PHE VAL GLY ASN ARG PHE GLN GLN SEQRES 32 B 411 LYS LEU ARG SER VAL PHE ARG VAL HET 8ES B1201 46 HET OLC B1202 14 HET OLA B1203 10 HETNAM 8ES N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2'-(2H-TETRAZOL-5-YL)[1, HETNAM 2 8ES 1'-BIPHENYL]-4-YL]METHYL}-3,4-DIHYDROQUINAZOLIN-6-YL) HETNAM 3 8ES THIOPHENE-2-CARBOXAMIDE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLA OLEIC ACID HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 8ES C36 H29 N7 O2 S FORMUL 3 OLC C21 H40 O4 FORMUL 4 OLA C18 H34 O2 FORMUL 5 HOH *(H2 O) HELIX 1 AA1 ASP B 1002 ALA B 1020 1 19 HELIX 2 AA2 ASN B 1022 ALA B 1043 1 22 HELIX 3 AA3 SER B 1055 GLU B 1081 1 27 HELIX 4 AA4 LYS B 1083 ALA B 1091 1 9 HELIX 5 AA5 GLN B 1093 TYR B 1105 1 13 HELIX 6 AA6 ASP B 45 GLN B 72 1 28 HELIX 7 AA7 LYS B 77 ALA B 95 1 19 HELIX 8 AA8 THR B 96 TYR B 106 1 11 HELIX 9 AA9 GLY B 113 TYR B 148 1 36 HELIX 10 AB1 PRO B 149 SER B 152 5 4 HELIX 11 AB2 GLN B 159 SER B 175 1 17 HELIX 12 AB3 SER B 175 PHE B 181 1 7 HELIX 13 AB4 PRO B 200 GLU B 202 5 3 HELIX 14 AB5 LYS B 203 PHE B 220 1 18 HELIX 15 AB6 PHE B 220 LYS B 240 1 21 HELIX 16 AB7 GLY B 245 GLY B 285 1 41 HELIX 17 AB8 SER B 289 CYS B 319 1 31 HELIX 18 AB9 PHE B 320 ASN B 323 5 4 HELIX 19 AC1 ARG B 324 ARG B 334 1 11 SHEET 1 AA1 2 ARG B 182 ILE B 187 0 SHEET 2 AA1 2 VAL B 192 MET B 197 -1 O VAL B 192 N ILE B 187 SSBOND 1 CYS B 35 CYS B 290 1555 1555 2.04 SSBOND 2 CYS B 117 CYS B 195 1555 1555 2.03 SITE 1 AC1 14 TYR B 51 TRP B 100 TYR B 103 LEU B 124 SITE 2 AC1 14 THR B 125 MET B 128 PHE B 129 THR B 178 SITE 3 AC1 14 ARG B 182 LYS B 215 TRP B 269 PHE B 272 SITE 4 AC1 14 ILE B 304 PHE B 308 SITE 1 AC2 6 PRO B 48 TYR B 52 THR B 102 SER B 105 SITE 2 AC2 6 ALA B 228 THR B 229 CRYST1 70.260 78.790 93.410 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014233 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012692 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010705 0.00000